| Adenosine A(2A) receptor antagonists are broad facilitators of antinicotinic neuromuscular blockade monitored either with 2 Hz train-of-four or 50 Hz tetanic stimuli. | |
| | |
MedLine Citation:
|
PMID: 23013133 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The 2 Hz train-of-four ratio (TOF(ratio) ) is used to monitor the degree of patient curarization. Using a rat phrenic nerve-hemidiaphragm preparation, we showed that antinicotinic agents, such as hexamethonium, d-tubocurarine and pancuronium, but not cisatracurium, decreased contractions produced by physiological nerve activity patterns (50 Hz) more efficiently than those caused by 2 Hz trains. Uncertainty about the usefulness of the TOF(ratio) to control safe recovery from curarization prompted us to investigate the muscarinic and adenosine neuromodulation of tetanic (50 Hz) fade induced by antinicotinic agents at concentrations that cause a 25% reduction in the TOF(ratio) (TOF(fade) ). Tetanic fade caused by d-tubocurarine (1.1 μmol/L), pancuronium (3 μmol/L) and hexamethonium (5.47 mmol/L) was attenuated by blocking presynaptic inhibitory muscarinic M(2) and adenosine A(1) receptors with methoctramine (1 μmol/L) and 1,3-dipropyl-8-cyclopentylxanthine (2.5 nmol/L), respectively. These compounds enhanced rather than decreased tetanic fade induced by cisatracurium (2.2 μmol/L), but they consistently attenuated cisatracurium-induced TOF(fade) . The effect of the M(1) receptor antagonist pirenzepine (10 nmol/L) on fade produced by antinicotinic agents at 50 Hz was opposite to that observed with TOF stimulation. Blockade of adenosine A(2A) receptors with ZM 241385 (10 nmol/L) attenuated TOF(fade) caused by all antinicotinic drugs tested, with the exception of the 'pure' presynaptic nicotinic antagonist hexamethonium. ZM 241385 was the only compound tested in this series that facilitated recovery from tetanic fade produced by cisatracurium. The data suggest that distinct antinicotinic relaxants interfere with fine-tuning neuromuscular adaptations to motor nerve stimulation patterns via activation of presynaptic muscarinic and adenosine receptors. These results support the use of A(2A) receptor antagonists together with atropine to facilitate recovery from antinicotinic neuromuscular blockade. |
| | |
Authors:
|
Monalisa W Pereira; Paulo Correia-de-Sá; Wilson Alves-Do-Prado |
Related Documents
:
|
9747783 - Semiquantitative reverse transcription-polymerase chain reaction analysis of mrna for g... 11390923 - Urocortin: a novel player in cardiac control. 10928453 - A hormone pulse induces transient changes in the subcellular distribution and leads to ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical and experimental pharmacology & physiology Volume: 39 ISSN: 1440-1681 ISO Abbreviation: Clin. Exp. Pharmacol. Physiol. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-09-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0425076 Medline TA: Clin Exp Pharmacol Physiol Country: Australia |
Other Details:
|
Languages: eng Pagination: 869-77 Citation Subset: IM |
Copyright Information:
|
© 2012 The Authors Clinical and Experimental Pharmacology and Physiology © 2012 Wiley Publishing Asia Pty Ltd. |
Affiliation:
|
Department of Pharmacology and Therapeutic, State University of Maringá, Maringa, Paraná, Brazil. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Matrix metalloproteinase-2 inhibition by temocapril and its important role in peritoneal transport.
Next Document: Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-...